Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
Operating Income
3,692.00
3,275.00
2,709.00
2,167.00
1,446.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
Net Sales
3,692.00
3,275.00
2,709.00
2,167.00
1,446.00
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
-2.00
-1.00
-2.00
-5.00
Raw Materials Consumed
882.00
761.00
626.00
545.00
353.00
Power & Fuel Cost
62.00
59.00
57.00
47.00
38.00
Employee Cost
824.00
734.00
635.00
567.00
466.00
Operating Expenses
9.00
5.00
17.00
5.00
2.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
29.00
29.00
24.00
3.00
2.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
85.00
88.00
58.00
50.00
54.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2,806.00
2,466.00
2,073.00
1,709.00
1,249.00
Operating Profit (PBDIT) excl Other Income
886.00
808.00
636.00
458.00
196.00
Other Income
79.00
74.00
49.00
38.00
31.00
Operating Profit (PBDIT)
965.00
883.00
685.00
496.00
228.00
Interest
74.00
83.00
86.00
86.00
72.00
Profit before Depriciation and Tax
890.00
799.00
599.00
410.00
155.00
Depreciation
193.00
172.00
149.00
129.00
123.00
Profit Before Taxation & Exceptional Items
697.00
627.00
449.00
280.00
32.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
647.00
627.00
449.00
280.00
32.00
Provision for Tax
165.00
149.00
123.00
84.00
3.00
Profit After Tax
481.00
478.00
326.00
196.00
28.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,764.00
1,283.00
952.00
768.00
737.00
Profit Available for appropriations
2,245.00
1,761.00
1,279.00
965.00
766.00
Appropriations
2,245.00
1,761.00
1,279.00
965.00
766.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
17.92
17.80
12.58
7.78
1.15
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 12.74% vs 20.86% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 9.54% vs 27.14% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -11.26% vs -2.95% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 0.68% vs 46.61% in Mar 2024
Compare Profit and Loss Results of Global Health
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
3,692.00
4,138.00
-446.00
-10.78%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
3,692.00
4,138.00
-446.00
-10.78%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
18.00
-20.00
-111.11%
Raw Materials Consumed
882.00
920.00
-38.00
-4.13%
Power & Fuel Cost
62.00
89.00
-27.00
-30.34%
Employee Cost
824.00
760.00
64.00
8.42%
Operating Expenses
9.00
1,235.00
-1,226.00
-99.27%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
29.00
119.00
-90.00
-75.63%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
85.00
28.00
57.00
203.57%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2,806.00
3,365.00
-559.00
-16.61%
Operating Profit (PBDIT) excl Other Income
886.00
773.00
113.00
14.62%
Other Income
79.00
148.00
-69.00
-46.62%
Operating Profit (PBDIT)
965.00
921.00
44.00
4.78%
Interest
74.00
132.00
-58.00
-43.94%
Profit before Depriciation and Tax
890.00
788.00
102.00
12.94%
Depreciation
193.00
248.00
-55.00
-22.18%
Profit Before Taxation & Exceptional Items
697.00
540.00
157.00
29.07%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
647.00
471.00
176.00
37.37%
Provision for Tax
165.00
134.00
31.00
23.13%
Profit After Tax
481.00
355.00
126.00
35.49%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,764.00
420.00
1,344.00
320.00%
Profit Available for appropriations
2,245.00
5,875.00
-3,630.00
-61.79%
Appropriations
2,245.00
5,875.00
-3,630.00
-61.79%
Equity Dividend (%)
0%
50%
-50.00
Earnings Per Share
17.92
107.98
-90.06
-83.40%
Profit And Loss - Net Sales
Net Sales 3,692.32 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 12.74% vs 20.86% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 886.15 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.54% vs 27.14% in Mar 2024
Profit And Loss - Interest
Interest 74.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -11.26% vs -2.95% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 481.32 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.68% vs 46.61% in Mar 2024






